BioShield is a U.S. government initiative that finances the stockpiling of drugs and vaccines against bioterror agents. A survey of 30 experts in biomedical research or drug and vaccine development, however, indicates that BioShield doesn't do enough to engage the private sector. @ A summary of the study, performed by the Sarnoff Corporation and the Center for Biosecurity of the University of Pittsburgh Medical Center, can be reached through SM Online.
By Jennifer L. Hesterman; reviewed by Hugh J. Martin
In The Terrorist-Criminal Nexus, Dr. Jennifer L. Hesterman presents the reader with a well-written catalog of the various terrorist factions presently active in the world. A colonel who has retired from the U.S. Air Force, the author has studied these groups in depth.